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MÜSKÜLER VENTRİKÜLER SEPTAL DEFEKTİN AMPLATZER DUKTAL OKLÜDER II 
İLE TRANSKATETER KAPATILMASI 
ÖZET
Ventriküler septal defektler transkateter tedavide kapatılması gereken 
bir defekt olarak görülmektedir. Son yıllarda yeni cihazların bulunması  ile 
birçok merkezde ventriküler septal defektlerin perkütan kapatılması  cesa-
retlendiren sonuçlarla uygulanmaktadır. Amplatzer oklüder sistemlerin son 
yıllarda kullanılmaya başlaması ile birlikte implantasyon sayılarında artma 
olmuştur. Bunun yanısıra, müsküler ventriküler septal defektlerin kapatıl-
masında birkaç cihaz kullanılabilmektedir. Bu yazıda 4 yaşında bir çocukta 
müsküler outlet ventriküler septal defektin Amplatzer Duktus Oklüder II ile 
başarılı bir şekilde kapatılmasını bildirmek istedik. 
Anahtar sözcükler: müsküler ventriküler septal defekt, transkateter kapatma, 
amplatzer duktus oklüder II
ABSTRACT
Ventricular septal defect has been targeted as a defect to close with tran-
scatheter methods. In recent years with the advent of new devices percu-
taneous closure of ventricular septal defect has been used in many centers 
with encouraging results. Introduction of Amplatzer occluder devices has 
been resulted in increase the number of implants in recent years. Beside 
this, a few devices can be used for transcatheter closure of muscular ventric-
ular septal defects. We report a successful transcatheter closure of muscular 
outlet ventricular septal defect in a 4 years of age child  with Amplatzer 
Ductal Occluder II.
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V entricular septal defect accounts for approxi-mately 30% of all congenital heart disease ; its prevalence is estimated at 1.17 per 1000 births and 
has increased recently because of improved detection (1). 
Although many of these defects are small and close spon-
taneously (2), the larger defects often persist to cause sig-
nificant shunt and pulmonary arterial hypertension. Since 
Porstmann et al (3) reported the first transcatheter closure 
of a patent ductus arteriosus in 1967, several interventional 
techniques have been developed to treat various intracar-
diac defects.  Ventricular septal defect had also been tar-
geted as the defect to close with a device several years ago 
(4,5). In recent years, new devices and refinement of tech-
niques, a number of reports on percutaneous closure of 
ventricular septal defect have been published with encour-
aging results. Percutaneous transcatheter closure of mus-
cular ventricular septal defect was first reported by Lock et 
al (4). Introduction of Amplatzer muscular ventricular sep-
tal defect occluder device has been resulted in increase the 
number of implants for ten years (6,7).  We report a success-
ful transcatheter closure of muscular outlet ventricular sep-
tal defect in a 4 years of age child  with Amplatzer Ductal 
Occluder II.
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Case report
Four years age boy, referred to our hospital who has pan-
systolic murmur and a history of recurrent lower respira-
tory tract infections. Clinically he had poor weight gain, 
signs of left ventricular volume overload, grade 3/6 pansys-
tolic murmur in left lower sternal edge. Electrocardiogram 
showed sinus rhythm with left QRS axis deviation and mild 
left ventricular hypertrophy. Chest radiograph showed 
cardiomegaly with increased pulmonary blood flow. 
Echocardiography showed situs solitus, levocardia, a four 
mm muscular outlet ventricular septal defect with left to 
right shunting on color flow doppler. The distance of the 
ventricular septal defect rim to aortic and atriooventricu-
lar valves was 12 and 10 mm respectively (Figure I). He had 
minimal aortic, mitral and tricuspid valve regurgitation and 
the signs of mild pulmonary arterial hypertension.
The patient then underwent complete right and left 
heart catheterization with continuous transesophageal 
echocardiography guidance under general anesthesia, 
which  confirmed the exact location and the size of the 
defect and hemodynamic status including pulmonary to 
systemic flow ratio and pulmonary vascular resistance. 
Pulmonary artery pressure was 40/32 mean of 35 mmHg 
when the aortic pressure 85/68 mean of 78 mm Hg. QP/
QS ratio was 1.3 and RP/RS ratio was 26,1%. Although the 
patient was symptomatic, and there was the signs of pul-
monary hypertension we decided to perform transcath-
eter ventricular septal defect closure. Written informed 
consent was obtained from the parents. 
Procedure
Transcatheter closure was performed under general anes-
thesia. Left ventricular angiography was performed in the 
long-axis view, and the size of the defect at the left ven-
tricular surface was measured in diastole (Figure 1). The 
ventricular septal defect was crossed from the left to right 
using a 5 F cut pigtail catheter and a 0.035” glide guide-
wire. The wire was then guided to the left pulmonary ar-
tery, and the catheter advanced over the wire through the 
ventricular septal defect. The glidewire was exchanged 
for a noodle wire, which was snared out from the right 
femoral vein, thus establishing a continuous arterio-
venous loop. Over this wire,  5F Amplatzer Duct Occluder 
II Occluder Device Delivery System was advanced into 
the left ventricle. Then, a Amplatzer PDA2-05-06 device 
(AGA Medical Corporation, Golden Valley, MN) was used 
to close the defect. The device (waist 5 mm, lenght 6 mm 
and disc diameters 11 mm each) attached to its deliv-
ery system was advanced through the sheath to the left 
ventricle. The distal disc was then extruded and pulled 
with the long sheath into the left ventricular surface of 
the defect. Left ventricular angiogram was repeated be-
side the transesophageal echocardiographic  examina-
tion. While maintaining tension on the delivery cable, the 
proximal disc was also deployed (Figure 2A-E). Left ven-
triculogram and transesophageal echocardiography were 
revealed that there was no shunt and the disks were in ap-
propriate side of the septum. After confirming that there 
was no impingement on either valve and no significant 
residual shunt, the device was released (Figure 2F).  A re-
peat left ventricular angiogram showed no residual shunt 
across the ventricular septal defect.  The total fluoroscopy 
time was 15 min, and the procedure time was 76 min. 
After 24 hours, repeat echocardiography showed that the 
device was in situ without any residual shunt. The patient 
was  discharged on 5 mg/kg daily aspirin. At follow-up of 
42 months, the patient is asymptomatic with no residual 
shunt and device related problem.
Discussion
This report describes an unusual use of Amplatzer Duct 
Occluder II device in a child with high muscular ventricu-
lar septal defect. Surgical closure of muscular ventricular 
septal defect still poses a significant surgical challenge. 
Various different surgical approaches have been pro-
posed; however, overall morbidity remain higher than 
with isolated perimembranous ventricular septal defects 
(8,9). Amplatzer muscular ventricular septal defect device 
has gained worldwide acceptance from the first used time 
and there are several reports describing effectiveness and 
safety of this device (6,7). Holzer and friends (10)  reported 
successfull results in 70 patients with hemodynamically 
significant muscular ventricular septal defects with per-
cutaneous approach. They experienced major complica-
tions in eight patients. A lower weight of the patient at the 
Figure 1. Transthoracic Echocardiography. Four chamber view demonstrated 
a 4 mm muscular ventricular septal defect (A); the distance between the 
superior rim of ventricular septal defect and AV valves was 11,4 mm (B).
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time of the procedure significantly correlated with an in-
creased risk of procedure-or device-related complications 
(10). In addition to the many advantages, the transcath-
eter treatment offers a shorter hospital stay. In patients 
with superiorly located muscular ventricular septal defect, 
one should be very careful for tricuspid valve apparatus 
and device interaction. In one previous study, one tem-
porary tricuspid valve incompetence, which was disap-
peared in 24 hours (11) . This finding may be explained by 
tricuspid valve septal leaflet chorda trapping by the right 
retention disk. Surgery was performed in one patient with 
superiorly located muscular ventricular septal defect in 
this study group to prevent permanent tricuspid valve 
damage. The postulated mechanisms for this complica-
tion may have been long waist lenght and relatively stiff 
disks of muscular ventricular septal defect closure device. 
In present case, a 6 mm Amplatzer muscular ventricular 
septal defect occluder (waist 6mm, lenght 7 mm and disk 
diameter 14 mm) would be appropriate. In that situation 
a 6F sheath should be needed to use a relatively large de-
vice with more metal inside the heart. We used Amplatzer 
Duct Occluder  II device, because of suitable feature for 
this highly located muscular ventricular septal defect.
The Amplatzer Duct Occluder  II  is a modification of the 
Amplatzer duct occluder I. There are no polyester patches 
and is made of fine Nitinol. The disks can swivel around 
the connecting waist adapting at different angles of PDA. 
The size of connecting waist ranges from 3 to 6 mm. The 
Amplatzer Duct Occluder  II  can be delivered via 4F to 5F 
low-profile braided and tapering sheath with flexible dis-
tal segment. The Amplatzer Duct Occluder  II  is not suit-
able for closure of PDAs >5.5 mm in diameter (12,13) . The 
Amplatzer Duct Occluder  II  was manufactured to solve 
some problems of the Amplatzer duct occluder I. The 
most important feature of the Amplatzer Duct Occluder  II 
is the very-low-profile disks, which can swivel around the 
connecting waist and adapt at different angles of PDA .The 
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Figure 2. Transcatheter Closure. Four chamber angiogram revealed high located muscular ventricular septal defect (A); the cut-pigtail catheter inside the 
pulmonary artery (B); arteriovenous loop creation (C); angiogram after the distal disk opened (D); angiogram after the distal and proximal  disk opened (E); 
position of the device after release (F).   
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Amplatzer Duct Occluder  II  can be implanted in small in-
fants with the use of low-profile sheaths. Thanopulos and 
friends (12) reported first experiences Amplatzer Duct 
Occluder  II  for PDA closure. The median age and weight 
of the patients were 3.2 years, 10.5 kg respectively. The 
mean PDA diameter was 3.6 ± 1.3 mm. Complete echo-
cardiographic closure of the ductus at 1-month follow-up 
was observed in 96% patients. 
Although the Amplatzer Duct Occluder II device are made 
to close the PDA, features; such as low profile, shape and 
the disk sizes; may be useful in cases with highly located 
muscular ventricular septal defect. In our case, the use of 
Amplatzer Duct Occluder  II  device was uneventful and 
the defect was completely closed. The major disadvan-
tage for the Amplatzer Duct Occluder  II  may be  relatively 
late disappearence of flow through the device, since there 
is no fabric inside the disks. This disadvantage may restrict 
the its usage in large defects. 
In conclusion, transcatheter device closure with 
Amplatzer Duct Occluder II device seems to be effec-
tive and safe in the treatment of  high located muscular 
ventricular septal defects. Although short term result is 
encouraging, we do not know the long term effectivity 
of this device. 
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